000 | 01838 a2200553 4500 | ||
---|---|---|---|
005 | 20250518003637.0 | ||
264 | 0 | _c20200114 | |
008 | 202001s 0 0 eng d | ||
022 | _a1421-9670 | ||
024 | 7 |
_a10.1159/000493325 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFurlano, Mónica | |
245 | 0 | 0 |
_aAutosomal Dominant Polycystic Kidney Disease: Clinical Assessment of Rapid Progression. _h[electronic resource] |
260 |
_bAmerican journal of nephrology _c2018 |
||
300 |
_a308-317 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAntidiuretic Hormone Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aClinical Decision-Making _xmethods |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xdiagnostic imaging |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOrgan Size |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 |
_aPolycystic Kidney, Autosomal Dominant _xdrug therapy |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTolvaptan _xtherapeutic use |
650 | 0 | 4 | _aUltrasonography |
700 | 1 | _aLoscos, Irene | |
700 | 1 | _aMartí, Teresa | |
700 | 1 | _aBullich, Gemma | |
700 | 1 | _aAyasreh, Nadia | |
700 | 1 | _aRius, Asunción | |
700 | 1 | _aRoca, Lourdes | |
700 | 1 | _aBallarín, José | |
700 | 1 | _aArs, Elisabet | |
700 | 1 | _aTorra, Roser | |
773 | 0 |
_tAmerican journal of nephrology _gvol. 48 _gno. 4 _gp. 308-317 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000493325 _zAvailable from publisher's website |
999 |
_c28964906 _d28964906 |